Neuromuscular electrical stimulation in early rehabilitation of Guillain‐Barré syndrome: A pilot study

ABSTRACT Introduction: In Guillain‐Barré syndrome (GBS), patients often develop muscle atrophy from denervation and immobilization. We, therefore, conducted a pilot study of neuromuscular electrical stimulation (NMES) to evaluate feasibility, safety, and effect on muscle wasting in the early phase o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Muscle & nerve 2019-04, Vol.59 (4), p.481-484
Hauptverfasser: Harbo, Thomas, Markvardsen, Lars Kjøbsted, Hellfritzsch, Michel Bach, Severinsen, Kåre, Nielsen, Jørgen Feldbæk, Andersen, Henning
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Introduction: In Guillain‐Barré syndrome (GBS), patients often develop muscle atrophy from denervation and immobilization. We, therefore, conducted a pilot study of neuromuscular electrical stimulation (NMES) to evaluate feasibility, safety, and effect on muscle wasting in the early phase of GBS. Methods: Seventeen patients were randomized to receive 20 min of muscle fiber stimulation followed by 40 min of NMES of the right or left quadriceps muscle with the untreated side as control. Cross‐sectional area (CSA) of the muscle measured by ultrasound and isometric knee extensor strength were the primary and secondary outcome measures. Results: No treatment related adverse effects were recorded. Change in CSA was ‐0.25 cm2 (confidence interval [CI], ‐0.93–0.42) on the stimulated side versus ‐0.60 cm2 (CI, ‐1.32–0.11) on the nonstimulated side (P = 0.08). No effect was observed on muscle strength. Conclusions: NMES seems safe and feasible in the early phase of GBS. Further studies are needed to explore effect on muscle function. Muscle Nerve 59:481–484, 2019
ISSN:0148-639X
1097-4598
DOI:10.1002/mus.26396